Formulation and Pharmacokinetics of Diclofenac Lipid Nanoemulsions for Parenteral Application

References

1. 1.↵
   1. Menasse R.,
   2. Hedwall P. R.,
   3. Kraetz J.,
   4. Pericin C.,
   5. Riesterer L.,
   6. Sallmann A.,
   7. Ziel R.,
   8. Jaques R.

   Pharmacological properties of diclofenac sodium and its metabolites. Scand. J. Rheumatol. 1978, 22, 5–16.

   OpenUrl
2. 2.↵
   1. Doreen M. S.,
   2. Boardman P. L.,
   3. Fowler P. D.,
   4. Poole P. H.

   Diclofenac (Voltarol) in rheumatoid arthritis: a report of a double blind trial. Rheumatology Rehabil. 1979, Suppl. 2, 78–80.
3. 3.↵
   1. Singh G.,
   2. Fort J. G.,
   3. Goldstein J. L.,
   4. Levy R. A.,
   5. Hanrahan P. S.,
   6. Bello A. E.,
   7. Andrade-Ortega L.,
   8. Wallemark C.,
   9. Agrawal N. M.,
   10. Eisen G. M.,
   11. Stenson W. F.,
   12. Triadafilopoulos G.,
   13. SUCCESS-I Investigators

   . Celecoxib verses naproxen and diclofenac in osteoarthritis patients SUCCESS-I study. Am. J. Med. 2006, 119 (3), 255–266.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Willis J.,
   2. Kendall M. J.,
   3. Flinn R. M.,
   4. Thornhill D. P.,
   5. Welling P G.

   The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur. J. Clin. Pharmacol. 1979, 16 (6), 405–410.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Kendall M. J.,
   2. Thornhill D. P.,
   3. Willis J. V.

   Factors affecting the pharmacokinetics of diclofenac sodium (Voltarol). Rheumatol Rehabil. 1979, Suppl. 2, 38–46.
6. 6.↵
   1. Kurowski M.

   Pharmacokinetics and biological activity of diclofenac preparation following intramuscular injection 75 mg and oral administration of 150 mg of active drug. Zeitschnft fur Rheumatologie 1988, 47,37–42.

   OpenUrl
7. 7.↵
   1. Carson J.,
   2. Notis W. M.,
   3. Orris E. S.

   Colonic ulceration and bleeding during diclofenac therapy. N. Engl. J. Med. 1990, 323 (2), 135.

   OpenUrlPubMed
8. 8.↵
   1. Lundberg B. B.

   Preparation of drug-carrier emulsions stabilized with phosphatidyl choline–surfactant mixtures. J. Pharm. Sci. 1994, 83 (1), 72–75.

   OpenUrlPubMed
9. 9.↵
   1. Lundberg B. B.

   A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of Paclitaxel (Taxol). J. Pharm. Pharmacol. 1997, 49 (1), 16–21.

   OpenUrlPubMedWeb of Science
10. 10.↵
    1. Nicolaos G.,
    2. Grauste-Manciet S.,
    3. Farinotti R.,
    4. Brossard D.

    Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion. Int. J. Pharm. 2003, 263 (1–2), 165–171.

    OpenUrlPubMed
11. 11.↵
    1. Jumaa M.,
    2. Müller B. W.

    The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int. J. Pharm. 1998, 163 (1), 81–89.

    OpenUrl
12. 12.↵
    1. Varshika E.,
    2. Prabhakar K.,
    3. Kishan V.

    Preparation, characterization, and in vivo pharmacodynamic evaluation of parenteral diclofenac submicron lipid emulsions. PDA J. Pharm. Sci. Technol. 2009, 63 (5), 308–389.

    OpenUrl
13. 13.↵
    1. Meyer S.,
    2. Berrut S.,
    3. Goodenough T. I. J.,
    4. Rajendram V. S.,
    5. Pinfield V. J.,
    6. Povey M. J. W.

    A comparative study of ultrasound and laser light diffraction techniques for particle size determination in dairy beverages. Measurement Sci. Technol. 2006, 17 (2), 289–297.

    OpenUrl
14. 14.↵
    1. Lieberman H. A.,
    2. Rieger M. M.,
    3. Banker G. S.

    Pharmaceutical Dosage Forms: Disperse Systems; Marcel Dekker: New York, 1988; Vol 1.
15. 15.↵
    1. Krishna G.,
    2. Wood G. C.,
    3. Sheth B. B.

    Improving emulsification efficacy of lecithin by formulation design. I. Effect of adding secondary surfactant. PDA J. Pharm. Sci. Technol. 1998, 52 (6), 331–336.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Sane R. T.,
    2. Samant R. S.,
    3. Nayak V. C.

    High performance liquid chromatographic determination of diclofenac sodium from pharmaceutical preparation. Drug Dev. Ind. Pharm. 1987, 13 (7), 1307–1314.

    OpenUrl
17. 17.↵
    1. Bucci R.,
    2. Magri A. D.,
    3. Magri A. L.

    Determination of diclofenac salts in pharmaceutical formulations. Fresenius' J. Analyt. Chem. 1998, 362 (7–8), 577–582.

    OpenUrl
18. 18.↵
    1. Jukanti R.,
    2. Devaraj G.,
    3. Devaraj R.,
    4. Apte S.

    Drug targeting to inflammation: Studies on antioxidant surface loaded diclofenac liposomes. Int. J. Pharm. 2011, 414 (1–2), 179–185.

    OpenUrlPubMed
19. 19.↵
    1. Patlolla R. R.,
    2. Vobalaboina V.

    Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. J. Pharm. Sci. 2005, 94 (2), 437–445.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Shotton E.,
    2. Davis S. S.

    A note on the stability of emulsion on high dilution. J. Pharm. Pharmacol. 1968, 20 (11), 825–829.

    OpenUrlPubMed
21. 21.↵
    1. Maranhão R. C.,
    2. Garicochea B.,
    3. Silva E. L.,
    4. Dorlhiac-Llacer P.,
    5. Cadena S. M.,
    6. Coelho I. J.,
    7. Meneghetti J. C.,
    8. Pileggi F. J.,
    9. Chamone D. A.

    Plasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemia. Cancer Res. 1994, 54 (17), 4660–4666.

    OpenUrlAbstract/FREE Full Text